Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes
Author:
Affiliation:
1. Department of Chemistry
2. Institute of Chemical Technology
3. Mumbai-400019, India
4. University of York
5. York-YO10 5DD, UK
Abstract
Much success has been achieved with platinum-based chemotherapeutic agents,i.e.through interactions with DNA. The long-term application of Pt complexes is thwarted by issues, leading scientists to examine other metals such as palladium which could exhibit complementary modes of action.
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2014/CS/C4CS00063C
Reference240 articles.
1. Platinum Compounds: a New Class of Potent Antitumour Agents
2. Structural aspects of platinum anticancer drug interactions with DNA
3. Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
4. New clues for platinum antitumor chemistry: Kinetically controlled metal binding to DNA
5. Cellular processing of platinum anticancer drugs
Cited by 333 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Synthesis of tetranuclear cyclopalladated complex using thiosemicarbazone derivative ligand: Spectral, biological and molecular docking studies;Journal of Molecular Structure;2025-02
2. New palladium(II) metallates containing ON donor Schiff base ligand. synthesis, spectral characterization, x-ray crystallography, photo physical and in vitro cytotoxicity;Journal of Molecular Structure;2024-11
3. Synthesis and Anticancer Activity of Palladium‐Butadienyl Complexes Bearing Picolyl‐NHC and Phosphine Ligands;European Journal of Inorganic Chemistry;2024-09-03
4. Structure-bioactivity relationship study on anticancer Pd and Pt complexes with aliphatic glycine derivative ligands;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-09
5. Palladium(II)-Indenyl Complexes Bearing N-Heterocyclic Carbene (NHC) Ligands as Potent and Selective Metallodrugs toward High-Grade Serous Ovarian Cancer Models;Journal of Medicinal Chemistry;2024-08-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3